Skip to main content

Avadel Pharmaceuticals PLC

AVDLDelisted Feb 12, 2026
Industry
Pharmaceutical Preparations
SEC CIK
0001012477

Avadel Pharmaceuticals PLC was delisted on Feb 12, 2026; its insiders filed their last Form 4 on Feb 18, 2026; 208 institutions reported holding it in 13F filings for Q4 2025, worth $1.60B in total; no superinvestor held it.

Q3 2021 vs. Q2 2021

How the institutions holding Avadel Pharmaceuticals PLC changed between Q2 2021 and Q3 2021.

All holders in Q3 2021All holders in Q2 2021

13F holders of AVDL: Q2 2021 compared with Q3 2021
MeasureQ2 2021Q3 2021Change
Holders8082+2
Shares32.6M32.1M−493.8K (−1.5%)
Value$219.1M$314.2M+$95.1M (+43.4%)

New holders (10)

Institutions that held Avadel Pharmaceuticals PLC at the end of Q3 2021 but not at the end of Q2 2021.

Institutions new to AVDL in Q3 2021
InstitutionSharesValue% of portfolio
MPM Oncology Impact Management LP400,000$3.92M0.61%
Group One Trading, L.P.66,888$656.0K0.01%
Cubist Systematic Strategies, LLC17,973$176.0K0.00%
Parallax Volatility Advisers, L.P.17,410$171.0K0.00%
Cetera Advisor Networks LLC10,526$103.0K0.00%
Valeo Financial Advisors, LLC10,000$98.0K0.01%
Belvedere Trading LLC10,134$86.0K0.02%
Quantbot Technologies LP5,800$56.0K0.00%
Ibex Wealth Advisors1,500$15.0K0.00%
Resources Management Corp400$4.00K0.00%

Sold out (8)

Institutions that held Avadel Pharmaceuticals PLC at the end of Q2 2021 and filed for Q3 2021 without it.

Institutions that sold out of AVDL in Q3 2021
InstitutionShares, Q2 2021Value, Q2 2021
Acuta Capital Partners, LLC561,011$3.78M
Pura Vida Investments, LLC176,206$1.19M
Squarepoint Ops LLC28,162$190.0K
Jane Street Group, LLC17,397$117.0K
Engineers Gate Manager LP13,800$93.0K
Jump Financial, LLC13,712$92.0K
Harbour Investments, Inc.300$2.00K
Parallel Advisors, LLC128$1.00K